ADAMI, Silvano
 Distribuzione geografica
Continente #
EU - Europa 18.575
NA - Nord America 18.461
AS - Asia 6.549
SA - Sud America 224
AF - Africa 27
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 9
Totale 43.869
Nazione #
US - Stati Uniti d'America 18.385
GB - Regno Unito 8.671
CN - Cina 3.730
SG - Singapore 2.184
RU - Federazione Russa 1.534
DE - Germania 1.503
FR - Francia 1.432
SE - Svezia 1.400
FI - Finlandia 1.194
IE - Irlanda 1.100
IT - Italia 941
UA - Ucraina 513
TR - Turchia 208
BR - Brasile 169
VN - Vietnam 140
JP - Giappone 89
BE - Belgio 70
NL - Olanda 58
CA - Canada 51
IR - Iran 32
CL - Cile 26
IL - Israele 24
KR - Corea 23
CZ - Repubblica Ceca 22
IN - India 21
AT - Austria 19
AU - Australia 19
ES - Italia 18
HK - Hong Kong 18
MX - Messico 16
PL - Polonia 15
EC - Ecuador 12
BG - Bulgaria 10
RO - Romania 10
CH - Svizzera 8
ZA - Sudafrica 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AR - Argentina 6
BD - Bangladesh 6
EG - Egitto 6
ID - Indonesia 6
IQ - Iraq 6
LT - Lituania 6
LV - Lettonia 6
HU - Ungheria 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PT - Portogallo 5
QA - Qatar 5
SA - Arabia Saudita 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
CM - Camerun 4
HR - Croazia 4
KG - Kirghizistan 4
LA - Repubblica Popolare Democratica del Laos 4
MD - Moldavia 4
PK - Pakistan 4
SK - Slovacchia (Repubblica Slovacca) 4
UZ - Uzbekistan 4
CO - Colombia 3
EE - Estonia 3
EU - Europa 3
JM - Giamaica 3
JO - Giordania 3
MA - Marocco 3
PE - Perù 3
TH - Thailandia 3
VE - Venezuela 3
AZ - Azerbaigian 2
CY - Cipro 2
DK - Danimarca 2
IM - Isola di Man 2
IS - Islanda 2
KW - Kuwait 2
LU - Lussemburgo 2
MY - Malesia 2
NP - Nepal 2
RS - Serbia 2
SC - Seychelles 2
TG - Togo 2
AM - Armenia 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MC - Monaco 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MS - Montserrat 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
Totale 43.861
Città #
Southend 8.019
Jacksonville 4.356
Chandler 2.545
Woodbridge 2.100
Singapore 1.705
Ann Arbor 1.668
Houston 1.174
Dublin 1.095
Ashburn 880
Wilmington 551
Lawrence 540
Princeton 540
Nanjing 424
Beijing 396
Jinan 391
Shenyang 337
New York 245
Sindelfingen 233
Boardman 228
Hebei 222
Helsinki 213
Milan 172
Verona 165
Tianjin 163
Changsha 158
Dong Ket 134
Nanchang 134
Haikou 122
Jiaxing 113
Ningbo 113
Zhengzhou 113
Hangzhou 100
Taizhou 97
Guangzhou 87
Tokyo 74
Falls Church 73
Taiyuan 71
Brussels 69
Norwalk 68
Santa Clara 67
Philadelphia 60
Detroit 56
Fairfield 56
Lanzhou 56
Los Angeles 52
Fuzhou 47
Lancaster 47
Seattle 41
Bologna 40
Dearborn 40
Washington 38
Düsseldorf 37
Redmond 35
Orani 33
Amsterdam 31
San Francisco 30
Auburn Hills 29
Redwood City 29
Toronto 28
Chicago 24
Dallas 23
Paris 23
Moscow 21
Columbus 20
Rome 19
Tappahannock 19
Frankfurt am Main 18
Greifswald 18
London 18
Nürnberg 18
Nuremberg 17
Cambridge 16
San Diego 16
São Paulo 16
West Jordan 16
Edinburgh 15
Sanayi 15
Kent 14
Phoenix 14
Romola 14
Vienna 14
Clearwater 13
Leawood 13
Mexico City 13
Warsaw 13
Dongguan 12
Hong Kong 11
Novokuznetsk 11
Olomouc 11
Venice 11
Seoul 10
Torino 10
Walsall 10
Brno 9
Mehlingen 9
Ypsilanti 9
Brasília 8
Hanover 8
Kemerovo 8
Quito 8
Totale 31.325
Nome #
1,25 (OH) 2D3 stimulates and bisphosphonates inhibit fibronectin release by human microphages. 275
1,25-dihydroxy vitamin D in primary hyperparathyroidism 273
Teriparatide and denosumab combination therapy and skeletal metabolism 250
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 179
Artrite Reumatoide e Metabolismo Minerale 175
Il trattamento del morbo di Paget con calcitonina umana: influenza della secrezione paratoidea e dei titoli di anticorpi anti-calcitonina (umana e porcina) 156
Trattamento dell'osteoporosi cortisonica con Nandrolone Decanoato 152
Association of CTR and COLIA1 alleles with BMD values in peri and postmenopausal women 146
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 145
12 month-retrospective analysis of two different rituximab retreatment regimens in rheumatoid arthritis:retreatment at clinical relapse Vs 6 (th) month fixed retreatment 144
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 142
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 142
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 137
Incidenza di ipovitaminosi D nel Nord Italia 136
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 135
Response of Paget's disease to human calcitonin in patients resistant to porcine calcitonin 133
12 month-retrospective analysis of two different Rituximab pretreatment regimens in Rheumatoid Arthritis: retreatment at clinical relapse versus 6th month fixed pretreatment. 132
Effects of therapeutic doses of salbutamol alone and combined with beclomethasone dipropionate on airway responsiveness and cyclic AMP plasma levels in asthmatic patients 130
25-OH-D metabolism in primary hyperparathyroidism 130
[Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate] 128
Discriminant analysis in the differential diagnosis of hypercalcaemia 127
[Studies on the therapeutic efficacy of a new diuretic combination in patients with edema of hepatic and cardiac etiology] 127
Sustained vertebral fracture risk reduction after withdrowal of teriparatide in postmenopausal women with osteoporosis 127
PAEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH GROUP A STREPTOCOCCAL INFECTION (PANDAS): CARDIAC AND ARTICULAR INVOLVEMENT 127
Serum thyroid hormone concentrations and weight loss relationships in eight obese women during semistarvation 126
[Therapeutic strategies in osteoporosis: whom and when to treat] 126
Fasting serum gastrin in primary hyperparathyroidism and in chronic hypercalcemia 124
[Acid-base balance in primary hyperparathyroidism] 124
[Serum calcium evaluation and incidence of primary hyperparathyroidism in hospitalized patients (author's transl)] 123
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 123
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 122
[Rational bases for the treatment of osteoporosis] 121
Primary hyperparathyroidism: diagnostic value of a model of multivariate statistical analysis 121
L'attività xantino-ossidasica epatocitaria nelle siderocromatosi primitive e secondarie 121
Age-related bone loss in postmenopausal women 121
Rapporti tra sistema immune e metabolismo osseo 121
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 121
[Incidence of thyroid diseases in primary hyperparathyroidism] 120
Circdian rhytm in serum PTH concentration in normal subjects and in primary hyperparathyroidoism: correlation with ionized serum calcium 120
DXA bone mineral density in males: retrospective study in real life. 117
The ultrastructure of bone cells and bone matrix in human primary hyperparathyroidism 117
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 117
Prevalence and incidence of rheumatoid arthritis in Italy. 117
Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases 116
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 115
Aberration in vitamin D metabolism during mianserin treatment [letter] 115
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 115
Coxibs: a significant therapeutic opportunity. 114
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 113
Effects of nandrolone decanoate (Decadurabolin) on serum Lp(a), lipids and lipoproteins in women with postmenopausal osteoporosis 113
Il dosaggio del calcio ionizzato nelle alterazioni del metabolismo fosfo-calcico 113
Valore del dosaggio radioimmunologico del paratormone plasmatico nella diagnosi di iperparatiroidismo primitivo 113
Analisi di linkage di geni candidati per densità minerale 113
Growth Hormone in Combination with Bisphosphonate Treatment in Osteogenesis Imperfecta. 112
Somatostatin inhibition of insulin secretion in insulin-producing tumors 111
Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment 110
A NEW CONCEPT FOR BISPHOSPHONATE THERAPY: A RATIONALE FOR THE DEVELOPMENT OF MONTHLY ORAL DOSING OF IBANDRONATE 110
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 110
Valutazione ecografia con power doppler delle entesi in età pediatrica 110
Digital Amputation in Systemic Sclerosis: Prevalence and Clinical Associations. A Retrospective Longitudinal Study. 110
Contributo allo studio del meccanismo d'azione ipouricemizzante del benziodarone 109
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 109
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 109
Adverse effects of bisphosphonates. A comparative review 108
Power Doppler ultrasonographic findings in healthy pediatric entheses 108
[Comparative studies of the behavior of blood calcium and urinary hydroxyproline after infusion of calcitonin and glucagon in patients with Paget's disease] 107
The renal handling of calcium: influence of parathyroid hormone secretion 107
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 107
The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis 107
Osteoporosis treatment: why ibandronic acid? 107
Simultaneous measurement of 1.25-dihydroxy-vitamin D, 24.25-dihydroxy-vitamin D and 25-hydroxy-vitamin D from a single two milliliters serum specimen. Preliminary clinical application 106
Effects of oral alendronate and intranasal samon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis 105
Osteopetrosi 105
Prevalence of osteoporosis in patients affected by mastocytosis 105
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 105
Safety issues and adverse reactions with osteoporosis management 105
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 105
Association between bone mineral density and serum lipid in men 104
Relation between adiponectin and bone mineral density in elderly post-menopausal women: role of body composition, leptin, insulin resistance, and dehydroepiandrosterone sulfate. 104
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 104
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 104
Long tem effects of the 25-hydroxychalciferol (25 OHD3) con PTH secretion in primary hyperparathyroid patients 103
Hypo-hyperparathyroidism with normal 1,25 dihydroxycholecalciferol. 103
Spie metaboliche precoci delle alterazioni ossee nell'iperparatiroidismo primitivo 103
Suppressive effect of chronic glucocorticoid treatment on circulating calcitonin in man 103
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 103
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 103
Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women 102
Primi rilievi sull'utilità del dosaggio radioimmunologico del paratormone nella diagnosi di iperparatiroidismo primitivo 102
Vitamin D levels in patients with psoriasis with or without arthritis 102
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 102
Antinuclear antibody profile in systemic sdclerosis patients who are negative for anticentromere and anti-topoisomerase I specificities 101
Anabolic steroids in corticosteroid-induced osteoporosis 101
Vitamin D metabolites in severe hypercalcemic parathyroid crises 101
Effetto della somministrazione cronica di 25-OH-colecalciferolo sui livelli plasmatici di PTH, 1.25(OH)2d e 24,25 (OH)2D, in pazienti affetti da iperparatiroidismo primitivo. 101
Incidenza di ipovitaminosi D nel Nord Italia 101
Intermittent etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH Agonist. 101
Failure of somatostatin to diagnose organic hyperinsulinism 101
The role of changes in calcitonin (CT), parathyroid hormone (PTH) and acid-base balance on the reduction of bone turnover (BT) after an oral calcium load (OCL) 100
Competitive protein binding assay for 25-hydroxyvitamin D. 100
Totale 12.126
Categoria #
all - tutte 141.381
article - articoli 132.021
book - libri 0
conference - conferenze 4.694
curatela - curatele 0
other - altro 832
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.834
Totale 282.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.396 0 0 0 0 0 0 0 724 254 550 134 734
2020/20215.125 472 921 159 482 618 613 40 495 435 24 597 269
2021/20223.764 255 941 33 133 264 217 41 236 178 122 437 907
2022/20237.875 707 527 981 1.247 764 1.866 64 514 788 57 252 108
2023/20243.313 204 295 305 498 453 386 121 257 34 108 410 242
2024/20254.179 680 796 349 1.408 419 161 362 4 0 0 0 0
Totale 44.159